|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PTH1R-1-E |
Parathyroid Hormone Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3200 |
0.38 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
1500 |
0.41 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.58 |
4.7 |
-8.46 |
4 |
7 |
0 |
113 |
282.344 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.77 |
2.07 |
-53.98 |
1 |
4 |
0 |
53 |
327.424 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.66 |
-3.5 |
-72.59 |
1 |
6 |
0 |
69 |
355.438 |
7 |
↓
|
|
|
Analogs
-
4073970
-
-
4536598
-
-
8579261
-
-
11592912
-
-
11592913
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 38 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
FKB1A-1-E |
FK506-binding Protein 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3600 |
0.38 |
Binding ≤ 10μM
|
Z50347-2-O |
Saccharomyces Cerevisiae (cluster #2 Of 3), Other |
Other |
88 |
0.49 |
Functional ≤ 10μM
|
Z50425-4-O |
Plasmodium Falciparum (cluster #4 Of 22), Other |
Other |
200 |
0.47 |
Functional ≤ 10μM
|
Z50466-5-O |
Trypanosoma Cruzi (cluster #5 Of 8), Other |
Other |
400 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
930 |
0.42 |
Functional ≤ 10μM
|
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
5000 |
0.37 |
Functional ≤ 10μM
|
Z80026-2-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
3600 |
0.38 |
Functional ≤ 10μM |
Z80224-6-O |
MCF7 (Breast Carcinoma Cells) (cluster #6 Of 14), Other |
Other |
1500 |
0.41 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
3500 |
0.38 |
Functional ≤ 10μM
|
Z80485-2-O |
SK-MEL-28 (Melanoma Cells) (cluster #2 Of 6), Other |
Other |
1000 |
0.42 |
Functional ≤ 10μM
|
Z80490-1-O |
SK-MES-1 (cluster #1 Of 4), Other |
Other |
2700 |
0.39 |
Functional ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 7), Other |
Other |
530 |
0.44 |
Functional ≤ 10μM
|
Z80653-1-O |
9L (Glioma Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.47 |
Functional ≤ 10μM
|
Z80874-4-O |
CEM (T-cell Leukemia) (cluster #4 Of 7), Other |
Other |
80 |
0.50 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
2500 |
0.39 |
Functional ≤ 10μM
|
Z81072-7-O |
Jurkat (Acute Leukemic T-cells) (cluster #7 Of 10), Other |
Other |
930 |
0.42 |
Functional ≤ 10μM
|
Z81170-3-O |
LNCaP (Prostate Carcinoma) (cluster #3 Of 5), Other |
Other |
1200 |
0.41 |
Functional ≤ 10μM
|
Z81247-6-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #6 Of 9), Other |
Other |
533 |
0.44 |
Functional ≤ 10μM
|
Z81252-4-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #4 Of 11), Other |
Other |
1200 |
0.41 |
Functional ≤ 10μM |
Z80005-2-O |
3T3 (Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
912 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.76 |
3.22 |
-17 |
2 |
5 |
0 |
83 |
281.352 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GCYA1-1-E |
Guanylate Cyclase Soluble Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5490 |
0.25 |
Binding ≤ 10μM
|
GCYB1-1-E |
Guanylate Cyclase Soluble Beta-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5490 |
0.25 |
Binding ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
2840 |
0.26 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.65 |
8.42 |
-43.44 |
2 |
7 |
1 |
70 |
409.51 |
10 |
↓
|
|
|
|
|
Analogs
-
3978074
-
-
4245659
-
-
4245660
-
-
4467870
-
-
11592709
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 37 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KITH-1-E |
Thymidine Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7000 |
0.38 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.60 |
Functional ≤ 10μM
|
Z80295-1-O |
MT4 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
4 |
0.62 |
Functional ≤ 10μM
|
Z102020-1-O |
Porcine Endogenous Retrovirus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50459-2-O |
Leishmania Donovani (cluster #2 Of 8), Other |
Other |
3400 |
0.40 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
7 |
0.60 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
46 |
0.54 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
9600 |
0.37 |
Functional ≤ 10μM
|
Z50609-1-O |
Simian Immunodeficiency Virus (cluster #1 Of 2), Other |
Other |
12 |
0.58 |
Functional ≤ 10μM
|
Z50658-1-O |
Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50664-1-O |
Rauscher Murine Leukemia Virus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50737-1-O |
Human Immunodeficiency Virus 3 (cluster #1 Of 1), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80071-1-O |
CEM-0 (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80073-1-O |
CEM-c113 (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
95 |
0.52 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
6180 |
0.38 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80294-1-O |
MT2 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z80384-1-O |
PBL (Peripheral Blood Lymphocytes) (cluster #1 Of 1), Other |
Other |
29 |
0.56 |
Functional ≤ 10μM
|
Z80516-1-O |
SUP-T1 (cluster #1 Of 1), Other |
Other |
50 |
0.54 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80683-1-O |
ATH8 Cell Line (cluster #1 Of 1), Other |
Other |
400 |
0.47 |
Functional ≤ 10μM
|
Z80688-1-O |
B(EBV+) Cell Line (cluster #1 Of 1), Other |
Other |
1 |
0.66 |
Functional ≤ 10μM
|
Z80721-1-O |
BxT Cell Line (cluster #1 Of 1), Other |
Other |
55 |
0.53 |
Functional ≤ 10μM
|
Z80737-1-O |
C3H/3T3 (Embryonic Fibroblast Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Functional ≤ 10μM
|
Z80760-1-O |
CFU-GM Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.43 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM |
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z81223-1-O |
M Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.58 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 4), Other |
Other |
700 |
0.45 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
45 |
0.54 |
ADME/T ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72874-1-V |
Human Immunodeficiency Virus Type 1 Protease (cluster #1 Of 3), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 1), Viral |
Viruses |
8 |
0.60 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.10 |
-3.76 |
-14.65 |
2 |
9 |
0 |
134 |
267.245 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.39 |
1.64 |
-34.48 |
1 |
2 |
1 |
13 |
282.407 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
85 |
0.38 |
Binding ≤ 10μM |
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
85 |
0.38 |
Binding ≤ 10μM |
LT4R2-1-E |
Leukotriene B4 Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
85 |
0.38 |
Binding ≤ 10μM |
LT4R2-1-E |
Leukotriene B4 Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
85 |
0.38 |
Binding ≤ 10μM
|
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
78 |
0.38 |
Functional ≤ 10μM
|
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
87 |
0.38 |
Functional ≤ 10μM
|
LT4R2-1-E |
Leukotriene B4 Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
78 |
0.38 |
Functional ≤ 10μM
|
LT4R2-1-E |
Leukotriene B4 Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.30 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
2874 |
0.30 |
Functional ≤ 10μM |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
7400 |
0.28 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.40 |
7.42 |
-46.55 |
1 |
7 |
-1 |
99 |
359.45 |
10 |
↓
|
Hi
High (pH 8-9.5)
|
4.40 |
8.43 |
-103.53 |
0 |
7 |
-2 |
102 |
358.442 |
10 |
↓
|
Mid
Mid (pH 6-8)
|
4.40 |
7.58 |
-16.03 |
2 |
7 |
0 |
101 |
360.458 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.98 |
8.66 |
-69.9 |
3 |
7 |
0 |
112 |
440.606 |
14 |
↓
|
Hi
High (pH 8-9.5)
|
3.46 |
6.41 |
-48.25 |
4 |
8 |
0 |
131 |
442.475 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
6100 |
0.35 |
Binding ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
6700 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.26 |
2.06 |
-11.27 |
0 |
3 |
0 |
35 |
347.208 |
5 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.49 |
3.82 |
-14.52 |
2 |
5 |
0 |
60 |
278.352 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.49 |
3.81 |
-14.22 |
2 |
5 |
0 |
60 |
278.352 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 61 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.43 |
6.59 |
-56.84 |
0 |
4 |
-1 |
66 |
179.151 |
3 |
↓
|
|
|
Analogs
-
11616941
-
-
11616943
-
-
27079413
-
-
43771549
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-1-E |
ADAM17 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
MMP14-3-E |
Matrix Metalloproteinase 14 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
84 |
0.43 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
200 |
0.41 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.47 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.52 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.49 |
Binding ≤ 10μM
|
ADA17-1-E |
ADAM17 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7000 |
0.31 |
Functional ≤ 10μM
|
TNFA-2-E |
TNF-alpha (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1001 |
0.37 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
4100 |
0.33 |
Functional ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 5), Other |
Other |
2100 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.38 |
0.45 |
-15.72 |
5 |
8 |
0 |
128 |
331.413 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
0.38 |
1.66 |
-56.16 |
4 |
8 |
-1 |
131 |
330.405 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CXCR2-1-E |
Interleukin-8 Receptor B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
320 |
0.45 |
Binding ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
339 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.81 |
-2.52 |
-11.33 |
3 |
7 |
0 |
107 |
273.248 |
3 |
↓
|
|
|
Analogs
-
8322482
-
-
5073087
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
2000 |
0.40 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.45 |
2.82 |
-12.42 |
0 |
3 |
0 |
35 |
268.312 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
7.18 |
-11.04 |
1 |
4 |
0 |
50 |
283.327 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
3.47 |
8.14 |
-43.86 |
0 |
4 |
-1 |
53 |
282.319 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
2230 |
0.33 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.42 |
13.76 |
-12.17 |
0 |
2 |
0 |
26 |
314.384 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
670 |
0.31 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.31 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.31 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.31 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
600 |
0.31 |
Functional ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
600 |
0.31 |
Functional ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
600 |
0.31 |
Functional ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
600 |
0.31 |
Functional ≤ 10μM
|
Z100709-1-O |
Squirrel Monkey (cluster #1 Of 1), Other |
Other |
600 |
0.31 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
8500 |
0.25 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
290 |
0.33 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.06 |
1.99 |
-9.25 |
0 |
3 |
0 |
31 |
373.496 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
5.06 |
2.1 |
-39.4 |
1 |
3 |
1 |
32 |
374.504 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCR3-1-E |
C-C Chemokine Receptor Type 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
CCR3-1-E |
C-C Chemokine Receptor Type 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.36 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
38 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.90 |
11.5 |
-23.09 |
1 |
7 |
0 |
101 |
378.384 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PAR1-1-E |
Proteinase Activated Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
550 |
0.17 |
Binding ≤ 10μM
|
PAR1-2-E |
Proteinase Activated Receptor 1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
280 |
0.17 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
800 |
0.16 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.96 |
-5.09 |
-98.07 |
18 |
19 |
2 |
343 |
749.915 |
25 |
↓
|
Mid
Mid (pH 6-8)
|
-2.09 |
-3.8 |
-58.3 |
17 |
19 |
1 |
344 |
748.907 |
24 |
↓
|
Mid
Mid (pH 6-8)
|
-1.96 |
-5.48 |
-61.09 |
17 |
19 |
1 |
342 |
748.907 |
25 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.51 |
14.97 |
-138.1 |
6 |
9 |
3 |
96 |
596.8 |
11 |
↓
|
Hi
High (pH 8-9.5)
|
5.51 |
14.61 |
-93.93 |
5 |
9 |
2 |
95 |
595.792 |
11 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PDE3A-2-E |
Phosphodiesterase 3A (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.46 |
Binding ≤ 10μM
|
PDE3B-2-E |
Phosphodiesterase 3B (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
69 |
0.40 |
Binding ≤ 10μM
|
PDE5A-2-E |
Phosphodiesterase 5A (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
7150 |
0.29 |
Binding ≤ 10μM
|
AA1R-1-E |
Adenosine A1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.31 |
Functional ≤ 10μM
|
AA2AR-1-E |
Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.31 |
Functional ≤ 10μM
|
AA2BR-1-E |
Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.31 |
Functional ≤ 10μM
|
AA3R-1-E |
Adenosine A3 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.31 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.28 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
1900 |
0.32 |
Functional ≤ 10μM
|
Z50592-1-O |
Oryctolagus Cuniculus (cluster #1 Of 8), Other |
Other |
2200 |
0.32 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
1200 |
0.33 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.99 |
8.23 |
-17.38 |
1 |
5 |
0 |
62 |
342.439 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AMPM2-1-E |
Methionine Aminopeptidase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
110 |
0.42 |
Binding ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.62 |
3.3 |
-54.66 |
6 |
6 |
1 |
106 |
360.887 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
3000 |
0.22 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
10.29 |
-21.51 |
3 |
8 |
0 |
122 |
477.513 |
13 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Hi
High (pH 8-9.5)
|
-0.93 |
3.82 |
-67.39 |
4 |
7 |
0 |
101 |
345.447 |
5 |
↓
|
Mid
Mid (pH 6-8)
|
-0.93 |
5.98 |
-99.31 |
5 |
7 |
1 |
103 |
346.455 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ITA2B-1-E |
Integrin Alpha-IIb (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6000 |
0.24 |
Binding ≤ 10μM |
ITB3-1-E |
Integrin Beta-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6000 |
0.24 |
Binding ≤ 10μM |
ITA2B-1-E |
Integrin Alpha-IIb (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10000 |
0.23 |
Functional ≤ 10μM |
ITB3-1-E |
Integrin Beta-3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10000 |
0.23 |
Functional ≤ 10μM |
Z50587-1-O |
Homo Sapiens (cluster #1 Of 1), Other |
Other |
6000 |
0.24 |
Binding ≤ 10μM |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
10000 |
0.23 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-4.79 |
0.21 |
-176.06 |
11 |
14 |
0 |
259 |
445.477 |
15 |
↓
|
Hi
High (pH 8-9.5)
|
-4.79 |
0.11 |
-139.7 |
10 |
14 |
-1 |
257 |
444.469 |
15 |
↓
|
Lo
Low (pH 4.5-6)
|
-4.79 |
-1.54 |
-133.75 |
12 |
14 |
1 |
256 |
446.485 |
15 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
7.50 |
13.41 |
-10.21 |
2 |
3 |
0 |
49 |
395.587 |
15 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.23 |
-0.39 |
-9.74 |
1 |
5 |
0 |
60 |
381.259 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.86 |
4.16 |
-46.86 |
5 |
10 |
1 |
143 |
421.474 |
10 |
↓
|
Ref
Reference (pH 7)
|
-0.99 |
4.3 |
-19.23 |
4 |
10 |
0 |
144 |
420.466 |
9 |
↓
|
Mid
Mid (pH 6-8)
|
-0.86 |
5.25 |
-32.88 |
4 |
10 |
0 |
146 |
420.466 |
10 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.71 |
10.02 |
-52.28 |
0 |
4 |
-1 |
53 |
356.345 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.12 |
5.36 |
-12 |
3 |
5 |
0 |
93 |
336.391 |
7 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
700 |
0.34 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
95 |
0.39 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
95 |
0.39 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
95 |
0.39 |
Binding ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 5), Other |
Other |
180 |
0.38 |
Binding ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
3467 |
0.31 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
4500 |
0.30 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
6120 |
0.29 |
Functional ≤ 10μM |
Z50592-1-O |
Oryctolagus Cuniculus (cluster #1 Of 8), Other |
Other |
800 |
0.34 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
1000 |
0.34 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
3630 |
0.30 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.37 |
10.45 |
-42.84 |
0 |
5 |
-1 |
82 |
342.415 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 18 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.92 |
3.02 |
-11.13 |
3 |
5 |
0 |
93 |
294.31 |
4 |
↓
|
|
|
Analogs
-
15683
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.75 |
0.03 |
-13.97 |
3 |
6 |
0 |
88 |
304.277 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
2.51 |
0.23 |
-46.69 |
2 |
6 |
-1 |
92 |
303.269 |
4 |
↓
|
|
|
Analogs
-
5333
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
298 |
0.42 |
Binding ≤ 10μM
|
LOX5-2-E |
Arachidonate 5-lipoxygenase (cluster #2 Of 7), Eukaryotic |
Eukaryotes |
70 |
0.46 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.75 |
0.04 |
-12.8 |
3 |
6 |
0 |
88 |
304.277 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
2.51 |
0.24 |
-45.52 |
2 |
6 |
-1 |
92 |
303.269 |
4 |
↓
|
|
|
Analogs
-
2000919
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 39 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
O77823-1-E |
Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE1A-1-E |
Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
800 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.38 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
40 |
0.52 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3690 |
0.38 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
622 |
0.43 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
Q864F1-1-E |
Phosphodiesterase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
720 |
0.43 |
Binding ≤ 10μM
|
Q8VBU5-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
625 |
0.43 |
Functional ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 1), Other |
Other |
150 |
0.48 |
Binding ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 5), Other |
Other |
7 |
0.57 |
Binding ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z100489-1-O |
Eosinophils (Eosinophils) (cluster #1 Of 1), Other |
Other |
6500 |
0.36 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
340 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
660 |
0.43 |
Functional ≤ 10μM |
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
4 |
0.59 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
40 |
0.52 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
1230 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.67 |
5.43 |
-11.26 |
1 |
4 |
0 |
48 |
275.348 |
4 |
↓
|
|
|
Analogs
-
4982
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 35 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
O77823-1-E |
Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE1A-1-E |
Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
800 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
740 |
0.43 |
Binding ≤ 10μM
|
PDE4A-1-E |
Phosphodiesterase 4A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4C-1-E |
Phosphodiesterase 4C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.42 |
Binding ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.41 |
Binding ≤ 10μM
|
Q864F1-1-E |
Phosphodiesterase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
720 |
0.43 |
Binding ≤ 10μM
|
Q8VBU5-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.59 |
Binding ≤ 10μM
|
PDE4B-1-E |
Phosphodiesterase 4B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
625 |
0.43 |
Functional ≤ 10μM
|
PDE4D-1-E |
Phosphodiesterase 4D (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.36 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 1), Other |
Other |
150 |
0.48 |
Binding ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 5), Other |
Other |
7 |
0.57 |
Binding ≤ 10μM |
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z100489-1-O |
Eosinophils (Eosinophils) (cluster #1 Of 1), Other |
Other |
6500 |
0.36 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
340 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
660 |
0.43 |
Functional ≤ 10μM |
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
4 |
0.59 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
40 |
0.52 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
1230 |
0.41 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.67 |
5.44 |
-11.23 |
1 |
4 |
0 |
48 |
275.348 |
4 |
↓
|
Ref
Reference (pH 7)
|
2.85 |
2.11 |
-7.58 |
1 |
4 |
0 |
51 |
275.348 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.34 |
9.05 |
-21.23 |
1 |
7 |
0 |
74 |
384.48 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.02 |
4.75 |
-10.47 |
1 |
7 |
0 |
101 |
314.363 |
5 |
↓
|
Mid
Mid (pH 6-8)
|
3.02 |
4.81 |
-35.55 |
0 |
7 |
-1 |
103 |
313.355 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.50 |
-1.97 |
-43.86 |
6 |
8 |
1 |
136 |
359.406 |
10 |
↓
|
|
|
Analogs
-
34588895
-
-
34599028
-
-
39017680
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 13 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
4000 |
0.76 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.48 |
1.47 |
-5.45 |
1 |
2 |
0 |
29 |
136.15 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.98 |
-5.89 |
-85.8 |
3 |
7 |
0 |
112 |
440.606 |
14 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.14 |
11.72 |
-52.55 |
0 |
4 |
-1 |
62 |
360.433 |
6 |
↓
|
Lo
Low (pH 4.5-6)
|
5.14 |
11.99 |
-61.9 |
1 |
4 |
0 |
63 |
361.441 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.36 |
Binding ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
2 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.01 |
-0.49 |
-47.21 |
4 |
7 |
1 |
99 |
456.607 |
13 |
↓
|
|
|
Analogs
-
896731
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 32 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CLTR2-1-E |
Cysteinyl Leukotriene Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1500 |
0.51 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
500 |
0.55 |
Binding ≤ 10μM
|
LOX5-1-E |
Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
830 |
0.53 |
Binding ≤ 10μM
|
LT4R1-1-E |
Leukotriene B4 Receptor 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
420 |
0.56 |
Binding ≤ 10μM
|
LKHA4-1-E |
Leukotriene A4 Hydrolase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
850 |
0.53 |
Functional ≤ 10μM
|
LOX5-2-E |
Arachidonate 5-lipoxygenase (cluster #2 Of 7), Eukaryotic |
Eukaryotes |
500 |
0.55 |
Functional ≤ 10μM
|
Z100741-2-O |
MC9 (Mast Cells) (cluster #2 Of 2), Other |
Other |
550 |
0.55 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
700 |
0.54 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
2400 |
0.49 |
Functional ≤ 10μM
|
Z50597-1-O |
Rattus Norvegicus (cluster #1 Of 12), Other |
Other |
2000 |
0.50 |
Functional ≤ 10μM
|
Z80419-1-O |
RBL-1 (Basophilic Leukemia Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.61 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.47 |
2.54 |
-10.68 |
3 |
4 |
0 |
67 |
236.296 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
2.47 |
3.13 |
-43.84 |
2 |
4 |
-1 |
69 |
235.288 |
2 |
↓
|
|